|
GB201716352D0
|
|
Compounds
|
|
GB201716374D0
|
|
Compounds
|
|
GB201716392D0
|
|
Compounds
|
|
GB201716369D0
|
|
Compounds
|
|
WO2018020366A1
|
|
Crystalline (r)-mandelate salt of (1r,2s)-2-phenylcyclopropylamine
|
|
WO2018002902A1
|
|
Antibody-drug conjugates and therapeutic methods using the same
|
|
WO2017203012A1
|
|
Epelsiban for use in the treatment of adenomyosis
|
|
WO2017202742A1
|
|
Pyridine dicarboxamide derivatives as bromodomain inhibitors
|
|
GB201705855D0
|
|
Novel compounds
|
|
GB201705856D0
|
|
Novel compounds
|
|
GB201705843D0
|
|
Novel compounds
|
|
GB201703273D0
|
|
Compounds
|
|
GB201703274D0
|
|
Compound
|
|
GB201703282D0
|
|
Compounds
|
|
GB201703283D0
|
|
Compounds
|
|
WO2017130156A1
|
|
Ingenol analogs, pharmaceutical compositions and methods of use thereof
|
|
WO2017085692A1
|
|
Pharmaceutical compositions of ribavirin
|
|
WO2017051355A1
|
|
Compounds with hiv maturation inhibitory activity
|
|
WO2017046739A1
|
|
Imidazolidinone derivatives as inhibitors of perk
|
|
TW201722957A
|
|
Chemical compounds
|
